sumatriptan has been researched along with Coronary Vasospasm in 18 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this review is to describe: the mechanisms of action of triptans; the case-reports of acute myocardial infarction (AMI) associated with sumatriptan use; and the results of studies evaluating its tolerability and safety." | 8.86 | Sumatriptan therapy for headache and acute myocardial infarction. ( Ames, PR; Barra, S; Gaeta, G; Lanero, S; Madrid, A; Materazzi, C; Vitagliano, G, 2010) |
"We report a case of myocardial infarction associated with the use of sumatriptan and review the literature regarding similar cases." | 7.75 | Acute myocardial infarction with sumatriptan: a case report and review of the literature. ( Chalaupka, FD, 2009) |
"The aim of this review is to describe: the mechanisms of action of triptans; the case-reports of acute myocardial infarction (AMI) associated with sumatriptan use; and the results of studies evaluating its tolerability and safety." | 4.86 | Sumatriptan therapy for headache and acute myocardial infarction. ( Ames, PR; Barra, S; Gaeta, G; Lanero, S; Madrid, A; Materazzi, C; Vitagliano, G, 2010) |
" Sumatriptan, a medication usually prescribed for acute migraine and cluster headaches has been documented as potentially causing coronary vasospasm, thereby leading to MI." | 3.96 | Vasospasm induced myocardial ischaemia secondary to sumatriptan use. ( Ojha, U; Okonkwo, K, 2020) |
"We report a case of myocardial infarction associated with the use of sumatriptan and review the literature regarding similar cases." | 3.75 | Acute myocardial infarction with sumatriptan: a case report and review of the literature. ( Chalaupka, FD, 2009) |
"Part 1 discusses the risks for Torsade de Pointes, vasospasm, and ischemia, with a review and discussion of case reports of triptan-associated cardiovascular events in migraineurs with and without CAD risk factors or documented CAD; of the epidemiology and studies of triptans, vasospasm, and cardiovascular morbidity; and of the relationship of variant angina, migraine, and vasospastic disease." | 2.49 | QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case. ( Cho, L; Stillman, MJ; Tepper, DE; Tepper, S, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (61.11) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 2 (11.11) | 24.3611 |
2020's | 2 (11.11) | 2.80 |
Authors | Studies |
---|---|
Vandebosch, C | 1 |
Dupont, M | 1 |
Verhaert, D | 1 |
Mullens, W | 1 |
Okonkwo, K | 1 |
Ojha, U | 1 |
Chalaupka, FD | 1 |
Barra, S | 1 |
Lanero, S | 1 |
Madrid, A | 1 |
Materazzi, C | 1 |
Vitagliano, G | 1 |
Ames, PR | 1 |
Gaeta, G | 1 |
Stillman, MJ | 1 |
Tepper, S | 1 |
Tepper, DE | 1 |
Cho, L | 1 |
Bassi, S | 1 |
Amersey, R | 1 |
Henderson, R | 1 |
Morris, GK | 1 |
Shimizu, M | 1 |
Hata, K | 1 |
Takaoka, H | 1 |
Kanazawa, K | 1 |
Shinke, T | 1 |
Matsumoto, H | 1 |
Watanabe, S | 1 |
Yoshikawa, R | 1 |
Masai, H | 1 |
Miyamoto, Y | 1 |
Akita, H | 1 |
Yokoyama, M | 1 |
Palmer, J | 1 |
Feldman, R | 1 |
Mancini, GB | 1 |
Zimmerman, M | 1 |
Walton-Shirley, M | 1 |
Flowers, K | 1 |
Whiteside, JH | 1 |
Lippolis, A | 1 |
Castini, D | 1 |
Cirino, D | 1 |
Ornaghi, M | 1 |
Peters, RH | 1 |
Meyburg, HW | 1 |
Westendorp, PH | 1 |
Westerhof, PW | 1 |
MacLean, MR | 1 |
Smith, GC | 1 |
Templeton, AG | 1 |
Mueller, L | 1 |
Gallagher, RM | 1 |
Ciervo, CA | 1 |
Porter, LM | 1 |
Deleu, D | 1 |
Hanssens, Y | 1 |
Willett, F | 1 |
Curzen, N | 1 |
Adams, J | 1 |
Armitage, M | 1 |
Castle, WM | 1 |
Simmons, VE | 2 |
Lloyd, DK | 1 |
Pilgrim, AJ | 1 |
3 reviews available for sumatriptan and Coronary Vasospasm
Article | Year |
---|---|
Sumatriptan therapy for headache and acute myocardial infarction.
Topics: Adolescent; Adult; Animals; Coronary Vasospasm; Female; Humans; Male; Middle Aged; Migraine Disorder | 2010 |
QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case.
Topics: Coronary Vasospasm; Electrocardiography; Female; Humans; Middle Aged; Migraine Disorders; Myocardial | 2013 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Des | 1999 |
2 trials available for sumatriptan and Coronary Vasospasm
Article | Year |
---|---|
Glyceryl trinitrate reversal of post-sumatriptan coronary artery narrowing.
Topics: Coronary Angiography; Coronary Disease; Coronary Vasospasm; Coronary Vessels; Humans; Injections, In | 1995 |
Coronary vasospasm and sumatriptan.
Topics: Chest Pain; Coronary Vasospasm; Humans; Indoles; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
13 other studies available for sumatriptan and Coronary Vasospasm
Article | Year |
---|---|
Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist in a patient with new-onset Graves' disease and myocarditis after SARS-CoV2 vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Coronary Vasospasm; COVID-19; COVID-19 Vaccines; Graves Disease; Humans | 2023 |
Vasospasm induced myocardial ischaemia secondary to sumatriptan use.
Topics: Coronary Angiography; Coronary Vasospasm; Electrocardiography; Humans; Male; Middle Aged; Migraine D | 2020 |
Acute myocardial infarction with sumatriptan: a case report and review of the literature.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aspirin; Coronary Vasospasm; Coronary Vessels; Echocardi | 2009 |
Thyrotoxicosis, sumatriptan and coronary artery spasm.
Topics: Coronary Angiography; Coronary Vasospasm; Female; Heart Arrest; Humans; Middle Aged; Migraine Disord | 2004 |
Sumatriptan provokes coronary artery spasm in patients with variant angina: possible involvement of serotonin 1B receptor.
Topics: Adult; Angina Pectoris, Variant; Coronary Vasospasm; Coronary Vessels; Female; Humans; Male; Middle | 2007 |
Unstable angina pectoris associated with Imitrex therapy.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Vasospasm; Electrocardiography; Female; H | 1995 |
[Coronary vasospasm secondary to subcutaneous administration of sumatriptan].
Topics: Adult; Coronary Angiography; Coronary Vasospasm; Diagnosis, Differential; Echocardiography; Female; | 1994 |
[Use of sumatriptan (Imigran) in a female patient with coronary spasm].
Topics: Adult; Coronary Angiography; Coronary Vasospasm; Ergotamine; Female; Humans; Migraine Disorders; Sum | 1994 |
Adverse reactions associated with sumatriptan.
Topics: Coronary Vasospasm; Drug Interactions; Humans; Indoles; Nitric Oxide; Serotonin Receptor Agonists; S | 1993 |
Vasospasm-induced myocardial infarction with sumatriptan.
Topics: Coronary Vasospasm; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; | 1996 |
What's causing angina in this headache patient?
Topics: Adult; Angina Pectoris; Coronary Vasospasm; Humans; Male; Migraine Disorders; Sumatriptan; Vasoconst | 1998 |
Coronary vasospasm induced by subcutaneous sumatriptan.
Topics: Coronary Vasospasm; Humans; Indoles; Injections, Subcutaneous; Male; Middle Aged; Sulfonamides; Suma | 1992 |
Coronary vasospasm and sumatriptan.
Topics: Coronary Vasospasm; Humans; Indoles; Sulfonamides; Sumatriptan | 1992 |